AI assistant
SYNTARA LIMITED — Director's Dealing 2007
Nov 15, 2007
65830_rns_2007-11-15_79dfe1e3-ccc3-45a6-825c-6273862bb857.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity PHARMAXIS LTD ABN 75 082 811 630
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | John Villiger |
|---|---|
| Date of last notice | 15 November 2006 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. | |
| Date of change | 5 November 2007 |
| No. of securities held prior to change | Options over ordinary shares: 200,000 |
| Class | Unlisted options |
| Number acquired | 200,000 options |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation | Granted under Pharmaxis Employee Option Plan for nilconsideration. Value of $322,340 using a Black Scholesoption pricing model. |
| No. of securities held after change | Options over ordinary shares: 200,000 |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestment plan,participation in buy-back | Grant of options under Pharmaxis Employee OptionPlan. The options were granted on 5 November 2007following approval at the 2007 annual general meetingof the Company and as advised to the ASX on 15November 2006 and 6 November 2007. |
|---|
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Part 2 – Change of director’s interests in contractsNote: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a direcdisclosed in this part.Detail of contractN/ANature of interest | Part 2 – Change of director’s interests in contractsNote: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a direcdisclosed in this part.Detail of contractN/ANature of interest | Part 2 – Change of director’s interests in contractsNote: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a direcdisclosed in this part.Detail of contractN/ANature of interest | tor” should be |
|---|---|---|---|
| Detail of contract | N/A | ||
| Nature of interest | |||
| Name of registered holder(if issued securities) | |||
| Date of change | |||
| No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed | |||
| Interest acquired | |||
| Interest disposed | |||
| Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation | |||
| Interest after change | |||
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002